SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)
The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by s...
Gespeichert in:
| Veröffentlicht in: | Clinical & translational oncology 2024-11, Vol.26 (11), p.2856-2865 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2865 |
|---|---|
| container_issue | 11 |
| container_start_page | 2856 |
| container_title | Clinical & translational oncology |
| container_volume | 26 |
| creator | Vaz-Salgado, María Ángeles García, Belén Cigarral Pérez, Isaura Fernández Munárriz, Beatriz Jiménez Domarco, Paula Sampedro González, Ainhoa Hernández Villar, María Vieito Caro, Raquel Luque Delgado, María Luisa Villamayor Sánchez, Juan Manuel Sepúlveda |
| description | The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available. |
| doi_str_mv | 10.1007/s12094-024-03456-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11467015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3046514060</sourcerecordid><originalsourceid>FETCH-LOGICAL-c398t-5b411a4fbb8f07674c347799aaba99d04a7f81256146699256c99b1b60f09c6c3</originalsourceid><addsrcrecordid>eNp9kDFPwzAUhC0EoqXwBxhQxjIEnmPHiSeEqlIqFToAs-U4TkiVxMVuUPn3GFJQWRgsn_XunU8fQucYrjBAcu1wBJyGEPlDaMzC7QEaYsZ5SCCOD_f0AJ04twKvGMbHaEBSxiKc4CHiT9PlQzibzh-XgaqrtlKyDsquyrV_aBcUxgallbkOoqCsK9NIF4wjiMjlKToqZO302e4eoZe76fPkPlwsZ_PJ7SJUhKebMM4oxpIWWZYWkLCEKkKThHMpM8l5DlQmRYojX4wyX9cLxXmGMwYFcMUUGaGbPnfdZY3OlW43VtZibatG2g9hZCX-TtrqVZTmXWCfmACOfcJ4l2DNW6fdRjSVU7quZatN5wQBymJMgYG3Rr1VWeOc1cXvPxjEF3TRQxceuviGLrZ-6WK_4e_KD2VvIL3B-VFbaitWprOtp_Zf7CeoNYqi</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3046514060</pqid></control><display><type>article</type><title>SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)</title><source>MEDLINE</source><source>Springer Nature - Complete Springer Journals</source><creator>Vaz-Salgado, María Ángeles ; García, Belén Cigarral ; Pérez, Isaura Fernández ; Munárriz, Beatriz Jiménez ; Domarco, Paula Sampedro ; González, Ainhoa Hernández ; Villar, María Vieito ; Caro, Raquel Luque ; Delgado, María Luisa Villamayor ; Sánchez, Juan Manuel Sepúlveda</creator><creatorcontrib>Vaz-Salgado, María Ángeles ; García, Belén Cigarral ; Pérez, Isaura Fernández ; Munárriz, Beatriz Jiménez ; Domarco, Paula Sampedro ; González, Ainhoa Hernández ; Villar, María Vieito ; Caro, Raquel Luque ; Delgado, María Luisa Villamayor ; Sánchez, Juan Manuel Sepúlveda</creatorcontrib><description>The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available.</description><identifier>ISSN: 1699-3055</identifier><identifier>ISSN: 1699-048X</identifier><identifier>EISSN: 1699-3055</identifier><identifier>DOI: 10.1007/s12094-024-03456-x</identifier><identifier>PMID: 38662171</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Astrocytoma - genetics ; Astrocytoma - pathology ; Astrocytoma - therapy ; Brain Neoplasms - genetics ; Brain Neoplasms - pathology ; Brain Neoplasms - therapy ; Clinical Guides in Oncology ; Glioma - genetics ; Glioma - pathology ; Glioma - therapy ; Humans ; Isocitrate Dehydrogenase - genetics ; Medicine ; Medicine & Public Health ; Neoplasm Grading ; Oligodendroglioma - genetics ; Oligodendroglioma - pathology ; Oligodendroglioma - therapy ; Oncology ; Societies, Medical</subject><ispartof>Clinical & translational oncology, 2024-11, Vol.26 (11), p.2856-2865</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c398t-5b411a4fbb8f07674c347799aaba99d04a7f81256146699256c99b1b60f09c6c3</cites><orcidid>0000-0003-3548-9961 ; 0000-0002-5913-9002</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12094-024-03456-x$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12094-024-03456-x$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,777,781,882,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38662171$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vaz-Salgado, María Ángeles</creatorcontrib><creatorcontrib>García, Belén Cigarral</creatorcontrib><creatorcontrib>Pérez, Isaura Fernández</creatorcontrib><creatorcontrib>Munárriz, Beatriz Jiménez</creatorcontrib><creatorcontrib>Domarco, Paula Sampedro</creatorcontrib><creatorcontrib>González, Ainhoa Hernández</creatorcontrib><creatorcontrib>Villar, María Vieito</creatorcontrib><creatorcontrib>Caro, Raquel Luque</creatorcontrib><creatorcontrib>Delgado, María Luisa Villamayor</creatorcontrib><creatorcontrib>Sánchez, Juan Manuel Sepúlveda</creatorcontrib><title>SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)</title><title>Clinical & translational oncology</title><addtitle>Clin Transl Oncol</addtitle><addtitle>Clin Transl Oncol</addtitle><description>The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available.</description><subject>Astrocytoma - genetics</subject><subject>Astrocytoma - pathology</subject><subject>Astrocytoma - therapy</subject><subject>Brain Neoplasms - genetics</subject><subject>Brain Neoplasms - pathology</subject><subject>Brain Neoplasms - therapy</subject><subject>Clinical Guides in Oncology</subject><subject>Glioma - genetics</subject><subject>Glioma - pathology</subject><subject>Glioma - therapy</subject><subject>Humans</subject><subject>Isocitrate Dehydrogenase - genetics</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasm Grading</subject><subject>Oligodendroglioma - genetics</subject><subject>Oligodendroglioma - pathology</subject><subject>Oligodendroglioma - therapy</subject><subject>Oncology</subject><subject>Societies, Medical</subject><issn>1699-3055</issn><issn>1699-048X</issn><issn>1699-3055</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><recordid>eNp9kDFPwzAUhC0EoqXwBxhQxjIEnmPHiSeEqlIqFToAs-U4TkiVxMVuUPn3GFJQWRgsn_XunU8fQucYrjBAcu1wBJyGEPlDaMzC7QEaYsZ5SCCOD_f0AJ04twKvGMbHaEBSxiKc4CHiT9PlQzibzh-XgaqrtlKyDsquyrV_aBcUxgallbkOoqCsK9NIF4wjiMjlKToqZO302e4eoZe76fPkPlwsZ_PJ7SJUhKebMM4oxpIWWZYWkLCEKkKThHMpM8l5DlQmRYojX4wyX9cLxXmGMwYFcMUUGaGbPnfdZY3OlW43VtZibatG2g9hZCX-TtrqVZTmXWCfmACOfcJ4l2DNW6fdRjSVU7quZatN5wQBymJMgYG3Rr1VWeOc1cXvPxjEF3TRQxceuviGLrZ-6WK_4e_KD2VvIL3B-VFbaitWprOtp_Zf7CeoNYqi</recordid><startdate>20241101</startdate><enddate>20241101</enddate><creator>Vaz-Salgado, María Ángeles</creator><creator>García, Belén Cigarral</creator><creator>Pérez, Isaura Fernández</creator><creator>Munárriz, Beatriz Jiménez</creator><creator>Domarco, Paula Sampedro</creator><creator>González, Ainhoa Hernández</creator><creator>Villar, María Vieito</creator><creator>Caro, Raquel Luque</creator><creator>Delgado, María Luisa Villamayor</creator><creator>Sánchez, Juan Manuel Sepúlveda</creator><general>Springer International Publishing</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3548-9961</orcidid><orcidid>https://orcid.org/0000-0002-5913-9002</orcidid></search><sort><creationdate>20241101</creationdate><title>SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)</title><author>Vaz-Salgado, María Ángeles ; García, Belén Cigarral ; Pérez, Isaura Fernández ; Munárriz, Beatriz Jiménez ; Domarco, Paula Sampedro ; González, Ainhoa Hernández ; Villar, María Vieito ; Caro, Raquel Luque ; Delgado, María Luisa Villamayor ; Sánchez, Juan Manuel Sepúlveda</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c398t-5b411a4fbb8f07674c347799aaba99d04a7f81256146699256c99b1b60f09c6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Astrocytoma - genetics</topic><topic>Astrocytoma - pathology</topic><topic>Astrocytoma - therapy</topic><topic>Brain Neoplasms - genetics</topic><topic>Brain Neoplasms - pathology</topic><topic>Brain Neoplasms - therapy</topic><topic>Clinical Guides in Oncology</topic><topic>Glioma - genetics</topic><topic>Glioma - pathology</topic><topic>Glioma - therapy</topic><topic>Humans</topic><topic>Isocitrate Dehydrogenase - genetics</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasm Grading</topic><topic>Oligodendroglioma - genetics</topic><topic>Oligodendroglioma - pathology</topic><topic>Oligodendroglioma - therapy</topic><topic>Oncology</topic><topic>Societies, Medical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vaz-Salgado, María Ángeles</creatorcontrib><creatorcontrib>García, Belén Cigarral</creatorcontrib><creatorcontrib>Pérez, Isaura Fernández</creatorcontrib><creatorcontrib>Munárriz, Beatriz Jiménez</creatorcontrib><creatorcontrib>Domarco, Paula Sampedro</creatorcontrib><creatorcontrib>González, Ainhoa Hernández</creatorcontrib><creatorcontrib>Villar, María Vieito</creatorcontrib><creatorcontrib>Caro, Raquel Luque</creatorcontrib><creatorcontrib>Delgado, María Luisa Villamayor</creatorcontrib><creatorcontrib>Sánchez, Juan Manuel Sepúlveda</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical & translational oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vaz-Salgado, María Ángeles</au><au>García, Belén Cigarral</au><au>Pérez, Isaura Fernández</au><au>Munárriz, Beatriz Jiménez</au><au>Domarco, Paula Sampedro</au><au>González, Ainhoa Hernández</au><au>Villar, María Vieito</au><au>Caro, Raquel Luque</au><au>Delgado, María Luisa Villamayor</au><au>Sánchez, Juan Manuel Sepúlveda</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)</atitle><jtitle>Clinical & translational oncology</jtitle><stitle>Clin Transl Oncol</stitle><addtitle>Clin Transl Oncol</addtitle><date>2024-11-01</date><risdate>2024</risdate><volume>26</volume><issue>11</issue><spage>2856</spage><epage>2865</epage><pages>2856-2865</pages><issn>1699-3055</issn><issn>1699-048X</issn><eissn>1699-3055</eissn><abstract>The 2021 World Health Organization (WHO) classification has updated the definition of grade 2 gliomas and the presence of isocitrate dehydrogenase (IDH) mutation has been deemed the cornerstone of diagnosis. Though slow-growing and having a low proliferative index, grade 2 gliomas are incurable by surgery and complementary treatments are vital to improving prognosis. This guideline provides recommendations on the multidisciplinary treatment of grade 2 astrocytomas and oligodendrogliomas based on the best evidence available.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>38662171</pmid><doi>10.1007/s12094-024-03456-x</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0003-3548-9961</orcidid><orcidid>https://orcid.org/0000-0002-5913-9002</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1699-3055 |
| ispartof | Clinical & translational oncology, 2024-11, Vol.26 (11), p.2856-2865 |
| issn | 1699-3055 1699-048X 1699-3055 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11467015 |
| source | MEDLINE; Springer Nature - Complete Springer Journals |
| subjects | Astrocytoma - genetics Astrocytoma - pathology Astrocytoma - therapy Brain Neoplasms - genetics Brain Neoplasms - pathology Brain Neoplasms - therapy Clinical Guides in Oncology Glioma - genetics Glioma - pathology Glioma - therapy Humans Isocitrate Dehydrogenase - genetics Medicine Medicine & Public Health Neoplasm Grading Oligodendroglioma - genetics Oligodendroglioma - pathology Oligodendroglioma - therapy Oncology Societies, Medical |
| title | SEOM-GEINO clinical guidelines for grade 2 gliomas (2023) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T19%3A21%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=SEOM-GEINO%20clinical%20guidelines%20for%20grade%202%20gliomas%20(2023)&rft.jtitle=Clinical%20&%20translational%20oncology&rft.au=Vaz-Salgado,%20Mar%C3%ADa%20%C3%81ngeles&rft.date=2024-11-01&rft.volume=26&rft.issue=11&rft.spage=2856&rft.epage=2865&rft.pages=2856-2865&rft.issn=1699-3055&rft.eissn=1699-3055&rft_id=info:doi/10.1007/s12094-024-03456-x&rft_dat=%3Cproquest_pubme%3E3046514060%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3046514060&rft_id=info:pmid/38662171&rfr_iscdi=true |